Brief: Codexis Enters Exclusive Licensing Agreement For Newly Engineered Double-Stranded Dna Ligase With Roche
26/02/2024 21:08
Codexis Inc CDXS.O :
* CODEXIS ENTERS EXCLUSIVE LICENSING AGREEMENT FOR NEWLY
ENGINEERED DOUBLE-STRANDED DNA LIGASE WITH ROCHE
* CODEXIS INC: UNDER TERMS OF DEAL, CODEXIS WILL RECEIVE
UPFRONT
AND TECHNICAL MILESTONE PAYMENTS
* CODEXIS INC: DEAL SUPERSEDES PRIOR EXCLUSIVE LICENSE ON
EVOT4™
DNA LIGASE
Source text for Eikon: ID:nGNX51JPP2
Further company coverage: CDXS.O
Recent news on Codexis
See all newsCodexis, Inc. reports results for the quarter ended June 30 - Earnings Summary
Codexis Q2 net loss narrows, helped by lower operating expenses
Codexis, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor